Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema

Am J Ophthalmol. 2003 Aug;136(2):384-6. doi: 10.1016/s0002-9394(03)00230-7.


Purpose: To report the clinical outcome of patients undergoing intravitreal injection of triamcinolone acetonide as treatment of long-standing cystoid macular edema after phacoemulsification.

Design: Prospective clinical interventional cases series studies.

Methods: The study included five patients suffering from cystoid macular edema after cataract surgery. They received an intravitreal injection of 25-mg crystalline triamcinolone acetonide transconjunctivally with topical anesthesia.

Results: In the follow-up period of 6.6 +/- 4.1 months, visual acuity increased from 0.26 +/- 0.13 to a mean maximal visual acuity of 0.60 +/- 0.19. For all patients, visual acuity improved during the follow-up by at least 0.20. Two (40%) patients developed intraocular pressure values higher than 21 mm Hg, which could be controlled by topical antiglaucomatous treatment.

Conclusions: Intravitreal triamcinolone acetonide may be a therapeutic option for long-standing cystoid macular edema after cataract surgery.

MeSH terms

  • Aged
  • Glucocorticoids / therapeutic use*
  • Humans
  • Injections / methods
  • Intraocular Pressure
  • Macular Edema / drug therapy*
  • Macular Edema / etiology
  • Phacoemulsification / adverse effects
  • Prospective Studies
  • Pseudophakia / drug therapy*
  • Treatment Outcome
  • Triamcinolone Acetonide / therapeutic use*
  • Visual Acuity
  • Vitreous Body / drug effects*


  • Glucocorticoids
  • Triamcinolone Acetonide